Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

110.06 -0.25 (-0.23%)
Streaming Delayed Price Updated: 11:42 AM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna Inc

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Delta and Moderna Share Good News
We've also got a look at money-related New Year's resolutions. 
Via The Motley Fool
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
For many investors, now would be an opportune time to take advantage of great stocks trading at a discount. 
Via The Motley Fool
Could This Opportunity Make Moderna a Hot Buy Again?
Merck and Moderna recently announced positive results from a trial involving their personalized cancer vaccine. 
Via The Motley Fool
2 Smartest Tech Stocks to Buy in 2022 and Beyond
The tech space is still bursting with opportunities for long-term investors. 
Via The Motley Fool
Tesla To $285? Here Are 10 Other Price Target Changes For Tuesday
Wells Fargo raised Ross Stores, Inc. (NASDAQ: ROST) price target from $120 to $135. Wells Fargo analyst Ike Boruchow maintained an Overweight rating on the stock. Ross Stores shares fell 0.9% to close... 
Via Benzinga
3 Top Stocks to Buy Before 2023
Here are some great bargains for long-term investors as we approach the end of the year. 
Via The Motley Fool
What 8 Analyst Ratings Have To Say About Moderna
Via Benzinga
Why This Moderna Analyst Is Turning Bullish On Drugmaker's Pipeline
Shares of Moderna Inc (NASDAQ: MRNA) rallied in premarket trading on Monday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
Via Benzinga
What's Going On With Moderna Stock Monday?
Moderna Inc (NASDAQ: MRNA) shares are trading higher Monday following positive analyst coverage from Jefferies.  
Via Benzinga
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5.  Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on... 
Via Benzinga
Why Shares Of COVID-19 Vaccine Maker Moderna Are Shooting Higher On Monday
Shares of coronavirus vaccine maker Moderna Inc. (NASDAQ: MRNA) were rallying in premarket trading on Monday. 
Via Benzinga
Hints Of Santa Rally As S&P 500, Nasdaq Futures Begin Week On Buoyant Note: Tesla, Moderna Stocks In Focus
The index futures are pointing to a moderately higher opening on Monday, as traders strive to shake off the negativity engendered by worries concerning the economy, inflation and interest rates. 
Via Benzinga
Are These Multibillion-Dollar Vaccine Stocks Still a Buy?
Moderna and Merck are up on the news regarding their melanoma cancer vaccine. 
Via The Motley Fool
5 No-Brainer Stocks to Buy Before 2023
These stocks are dirt cheap today. But low valuations may not last for long. 
Via The Motley Fool
3 Beaten-Down Stocks That Could Explode Higher in 2023
These stocks could have significant upside opportunities ahead. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
Moderna spiked on a cancer vaccine while Tesla continued to dive. 
Via Investor's Business Daily
Why Is Novavax (NVAX) Stock Down 10% Today?
Novavax is conducting a public offering of 6.5 million shares. Here's why the news is pushing NVAX stock down. 
Via InvestorPlace
2 Biotech Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Two drug developers stand out as plain-as-day bargains in the new year, while another top-performing biotech stock looks poised to disappoint. 
Via The Motley Fool
BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
Via Benzinga
3 Growth Stocks With More Potential Than Any Cryptocurrency
If the crypto meltdown has you discouraged, don't give up on stocks. 
Via The Motley Fool
Why Is Novavax (NVAX) Stock Plunging Today?
NVAX stock is down today on fundraising plans. Here's what investors should know about this once-promising Covid-19 vaccine player. 
Via InvestorPlace
Is Moderna a Good Stock to Buy Right Now?
Recent results suggest the company's cancer vaccine candidate can succeed where others have failed. 
Via The Motley Fool
Moderna Stock Shows Surprising Strength; Key Rating Upgraded
See if Moderna stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day average. 
Via Investor's Business Daily
7 Stocks to Buy on the Dip as the S&P 500 Falters
Investors looking for a margin of safety and growth even in a recession should consider these cheap stocks to buy on the dip. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Most Active Equity Options For Midday - Wednesday, Dec. 14
Here are the most active equity options for midday. 
Via Talk Markets
Why Moderna Shares Are Rising Again Today
Moderna Inc (NASDAQ: MRNA) shares are trading higher by 8.5% to $214.34 on continued upward momentum after the company and Merck announced mRNA-4157/V940 in combination with KEYTRUDA, met the primary... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.